Spiral computed tomography versus ultrasound in the follow-up of cirrhotic patients previously treated for hepatocellular carcinoma: A prospective study

Journal of Hepatology

Volumn 39, Issue 1, 2003, Pages 93-98

  Colagrande, Stefano ^a   La Villa, Giorgio ^a   Bartolucci, Maurizio ^a   Lanini, Fabio ^a   Barletta, Giuseppe ^b   Villari, Natale ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cirrhosis; Diagnosis; Recurrent hepatocellular carcinoma; Spiral computed tomography; Ultrasonography; Fetoprotein

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TUMOR RECURRENCE; ULTRASOUND;

EID: 0038310774     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00159-4     Document Type: Article

References (28)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-85.
2. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-8.
3. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs A, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona - 2000 EASL conference. J Hepatol 2001;35:421-30.
4. Bennett GL, Krinsky GA, Abitbol RJ, Kim SY, Theise ND, Teperman LW. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. Am J Roentgenol 2002;179:75-80.
5. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995;221:291-8.
6. Schwartz JD, Schwartz M, Mandali J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomized clinical trials. Lancet Oncol 2002;3:593-603.
7. Hollett MD, Jeffrey RB, Nino-Murcia M, Jorgensen MJ, Harris DP. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< 1.5 cm) malignant hepatic neoplasms. Am J Roentgenol 1995;164:879-84.
8. Ohashi I, Hanafusa K, Yoshida T. Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation. Radiology 1993;189:851-5.
9. Takayasu K, Furukawa H, Wakao F, Muramatsu Y, Abe H, Terauchi T, et al. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. Am J Roentgenol 1995;164:885-90.
10. Bonaldi VM, Bret PM, Reinhold C, Atri M. Helical CT of the liver: value of an early hepatic arterial phase. Radiology 1995;197:357-63.
11. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MR, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
12. Colagrande S, Fargnoli R, Dal Pozzo F, Bindi A, Rega L, Villari N. Value of hepatic arterial phase CT versus lipiodol ultrafluid CT in the detection of hepatocellular carcinoma. J Comput Assist Tomogr 2000;24:878-83.
13. Choi BI, Takayasu K, Han MC. Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings. Am J Roentgenol 1993;160:1177-87.
14. Choi BI, Lee HJ, Han JK, Choi DS, Seo JB, Han MC. Detection of hypervascular nodular hepatocellular carcinomas: value of triphasic helical CT compared with iodized-oil CT. Am J Roentgenol 1997;168:219-24.
15. Itai Y, Matsui O. Blood flow and liver imaging. Radiology 1997;202:306-14.
16. Craig JR, Klatt EC, Yu M. Role of cirrhosis and development of HCC: evidence from histologic studies and large population studies. In: Tabor E, Di Bisceglie AM, Purcell RH, editors. Etiology, pathology, and treatment of hepatocellular carcinoma in North America. Houston, TX: Portfolio Publishing; 1991. p. 177-90.
17. Dodd GD, Miller WJ, Baron RL. Detection of malignant tumors in end stage cirrhotic livers: efficacy of sonography as a screening technique. Am J Roentgenol 1992;159:727-33.
18. Imari Y, Sakamoto S, Shiomichi S. Hepatocellular carcinoma not with plain US: treatment with percutaneous ethanol injection under guidance with enhanced US. Radiology 1992;185:497-500.
19. Nakashima T, Kojiro M. Hepatocellular carcinoma. Tokyo: Springer; 1987.
20. Peterson MS, Baron RL. Radiologic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001;5:123-44.
21. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132-7.
22. Numata K, Isozaki T, Ozawa Y, Sakaguchi T, Kiba T, Kubota T, et al. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. Am J Roentgenol 2003;180:143-9.
23. Baron RL, Marsh W, Oliver III JH, Confer S, Hunt LE, Peterson MS. Screening cirrhosis for hepatocellular carcinoma (HCC) with helical contrast CT: specificity [abstract]. Radiology 1997;205P:143.
24. Ueda K, Terada T, Nakanuma Y, Matsui O. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol 1992;23:619-26.
25. Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999;30:889-93.
26. Krinsky GA, Theise ND, Rofsky NM, Mizrachi H, Tepperman LW, Weinreb JC. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging-a case report. Radiology 1998;209:461-4.
27. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-24.
28. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-42.